首页>美国卫生研究院文献>Therapeutic Advances in Medical Oncology

Therapeutic Advances in Medical Oncology

【机译】：在肿瘤内科治疗进展

ISSN：-
出版周期：Bimonthly
语言：English

起始发布年份：2009
出版者：London : Sage
出版地：England

数据库引入：PubMed: v1, 2009-, PMC

MeSH词表主题词：Neoplasms/therapy*

备注：Description based on: Vol. 1, no. 1 (July 2009); title from cover. Latest issue展开▼

期刊论文

热门论文

年度选择

更多>>

全选（0）

1.Interpretation of survival data: which graphical analysis is appropriate?

机译：生存数据的解释：哪种图形分析合适？
- 作者：Omer Dizdar;Serkan Akin;Mutlu Hayran
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第4期
2.Exosome-mediated drug resistance in cancer: the near future is here

机译：外来体介导的癌症耐药性：不久的将来就在这里
- 作者：Marco Giallombardo;Simona Taverna;Riccardo Alessandro;David Hong;Christian Rolfo
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第5期
3.Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors

机译：长期去势抵抗性前列腺癌及随之而来的心血管危险因素的患者长期暴露于乙酸阿比特龙的安全性
- 作者：Elena Verzoni;Paolo Grassi;Raffaele Ratta;Monica Niger;Filippo De Braud;Riccardo Valdagni;Giuseppe Procopio
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第5期
- abiraterone acetate cardiovascular risk factors castration-resistant prostatic cancer prostate cancer retrospective study safety;
4.Ultrasound-guided radiofrequency ablation for cT1a renal masses in poor surgical candidates: mid-term single-center outcomes

机译：超声引导射频消融治疗不良手术候选人中的cT1a肾肿块：中期单中心预后
- 作者：Ioannis Zachos;Konstantinos Dimitropoulos;Anastasios Karatzas;Michael Samarinas;Argiro Petsiti;Vassilios Tassoudis;Vassilios Tzortzis
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第5期
- frail radiofrequency ablation renal cancer small renal masses ultrasound unfit;
5.Neratinib in HER-2-positive breast cancer: results to date and clinical usefulness

机译：Neratinib在HER-2阳性乳腺癌中的作用：迄今为止的结果和临床意义
- 作者：Arlene Chan
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第5期
- HER-2-positive breast cancer neratinib tyrosine kinase inhibitor;
6.Concepts and targets in triple-negative breast cancer: recent results and clinical implications

机译：三阴性乳腺癌的概念和目标：最新结果和临床意义
- 作者：Poornima Saha;Rita Nanda
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第5期
- targeted therapy therapeutic targets in triple-negative breast cancer triple-negative breast cancer;
7.Strategies to modulate the immune system in breast cancer: checkpoint inhibitors and beyond

机译：调节乳腺癌免疫系统的策略：检查点抑制剂及其他
- 作者：Cristina Migali;Monica Milano;Dario Trapani;Carmen Criscitiello;Angela Esposito;Marzia Locatelli;Ida Minchella;Giuseppe Curigliano
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第5期
- breast cancer immune-checkpoint inhibitor immunotherapy;
8.Hedgehog pathway inhibition in advanced basal cell carcinoma: latest evidence and clinical usefulness

机译：晚期基底细胞癌的刺猬通路抑制作用：最新证据和临床意义
- 作者：Sirunya Silapunt;Leon Chen;Michael R. Migden
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第5期
- basal cell carcinoma Hedgehog pathway inhibitor sonidegib vismodegib;
9.Emergency therapy for liver metastases from advanced VIPoma: surgery or transarterial chemoembolization?

机译：晚期VIPoma肝转移的紧急治疗：手术还是经动脉化学栓塞？
- 作者：Johann Dréanic;Céline Lepère;Mostafa El Hajjam;Hervé Gouya;Philippe Rougier;Romain Coriat
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第5期
- hepatectomy neuroendocrine tumors (NET) systemic chemotherapy transarterial chemo embolization (TACE) vasoactive intestinal peptide (VIP) VIPoma;
10.Targeting intratumoral androgens: statins and beyond

机译：靶向肿瘤内雄激素：他汀类药物及其他
- 作者：Michael T. Schweizer;Evan Y. Yu
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第5期
- androgen receptor castration-resistant prostate cancer drug resistance microenvironment prostate cancer statin steroidogenesis;
11.Neurokinin-1 inhibitors in the prevention of nausea and vomiting from highly emetogenic chemotherapy: a network meta-analysis

机译：Neurokinin-1抑制剂在预防高致呕性化疗引起的恶心和呕吐中的作用：网络荟萃分析
- 作者：Omar Abdel-Rahman
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第5期
- chemotherapy nausea neurokinin vomiting;
12.Efficacy and toxicity of salvage weekly paclitaxel chemotherapy in non-Asian patients with advanced oesophagogastric adenocarcinoma

机译：每周一次紫杉醇抢救性化疗在非亚洲晚期食管胃腺癌患者中的疗效和毒性
- 作者：Noelia Tarazona;Elizabeth C. Smyth;Clare Peckit;Ian Chau;David Watkins;Sheela Rao;Naureen Starling;David Cunningham
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第2期
- gastric cancer gastro-oesophageal cancer oesophageal cancer oesophagogastric adenocarcinoma paclitaxel salvage chemotherapy second-line chemotherapy;
13.Novel targets in the treatment of advanced gastric cancer: a perspective review

机译：新型靶点治疗晚期胃癌：前景回顾
- 作者：Elisa Fontana;Elizabeth C. Smyth
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第2期
- chromosomal instability clinical trials Epstein Barr virus gastric cancer gastroesophageal cancer genomically stable microsatellite instability molecular profiling The Cancer Genome Atlas;
14.Targeting dormant micrometastases: rationale evidence to date and clinical implications

机译：靶向休眠微转移：理论依据最新证据和临床意义
- 作者：Robert E. Hurst;Anja Bastian;Lora Bailey-Downs;Michael A. Ihnat
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第2期
- dormant cancer cells micrometastatic cells prevention;
15.Treatment approach in patients with hyperbilirubinemia secondary to liver metastases in gastrointestinal malignancies: a case series and review of literature

机译：胃肠道恶性肿瘤继发于肝转移的高胆红素血症患者的治疗方法：病例系列及文献复习
- 作者：Julia Quidde;Marc Azémar;Carsten Bokemeyer;Dirk Arnold;Alexander Stein
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第3期
- chemotherapy gastrointestinal cancer hyperbilirubinemia liver dysfunction liver metastases;
16.Phase II study of gemcitabine plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy

机译：铂类化疗失败后吉西他滨联合S-1化疗对复发和转移性鼻咽癌患者的II期研究
- 作者：PeiJian Peng;XueQing Ou;Hai Liao;YuMeng Liu;SiYang Wang;ZhiBin Cheng;Zhong Lin
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第3期
- gemcitabine nasopharyngeal carcinoma platinum S-1;
17.The preoperative platelet–lymphocyte ratio versus neutrophil–lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma?

机译：术前血小板与淋巴细胞的比例与中性粒细胞与淋巴细胞的比例：哪个更好作为口腔鳞状细胞癌的预后因素？
- 作者：Shan Chen;Junbing Guo;Chongjin Feng;Zunfu Ke;Leihui Chen;Yunping Pan
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第3期
- neutrophil to lymphocyte ratio oral squamous cell carcinoma platelet to lymphocyte ratio prognostic factor;
18.Immunotherapy for head and neck cancer: latest developments and clinical potential

机译：头颈癌的免疫疗法：最新进展和临床潜力
- 作者：Joshua M. Bauml;Roger B. Cohen;Charu Aggarwal
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第3期
- head and neck cancer immunotherapy PD-1 inhibitors cancer vaccines adoptive cellular therapies;
19.Overcoming resistance to first/second generation epidermal growth factor receptor tyrosine kinase inhibitors and ALK inhibitors in oncogene-addicted advanced non-small cell lung cancer

机译：在致癌基因上瘾的晚期非小细胞肺癌中克服对第一代/第二代表皮生长因子受体酪氨酸激酶抑制剂和ALK抑制剂的耐药性
- 作者：Ourania Romanidou;Lorenza Landi;Federico Cappuzzo;Raffaele Califano
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第3期
- AZD9291 ceritinib crizotinib EGFR-TKIs EML-ALK gene rearrangement epidermal growth factor receptor mutations resistance rociletinib;
20.Nintedanib in NSCLC: evidence to date and place in therapy

机译：Nintedanib在NSCLC中的作用：迄今为止的证据和治疗证据
- 作者：Giuseppe Bronte;Francesco Passiglia;Antonio Galvano;Nadia Barraco;Angela Listì;Marta Castiglia;Sergio Rizzo;Eugenio Fiorentino;Viviana Bazan;Antonio Russo
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第3期
- angiogenesis FGFR nintedanib NSCLC PDGFR targeted therapy VEGFR;
21.Pemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomes

机译：培美曲塞治疗晚期非鳞状非小细胞肺癌：有关其广泛使用和疗效的最新证据
- 作者：Pascale Tomasini;Fabrice Barlesi;Celine Mascaux;Laurent Greillier
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第3期
- lung cancer nonsquamous pemetrexed survival tolerability;
22.Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in metastatic breast cancer: which benefit for which patients?

机译：纳米粒子结合白蛋白的紫杉醇（nab-紫杉醇）靶向化疗在转移性乳腺癌中的作用：对哪些患者有益？
- 作者：Raffaella Palumbo;Federico Sottotetti;Antonio Bernardo
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第3期
- metastatic breast cancer nab-paclitaxel taxanes;
23.Ramucirumab in metastatic colorectal cancer: evidence to date and place in therapy

机译：雷莫昔单抗治疗转移性结直肠癌的证据
- 作者：Helena Verdaguer;Josep Tabernero;Teresa Macarulla
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第3期
- angiogenesis colorectal cancer metastatic ramucirumab vascular endothelial growth factor;
24.Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential

机译：用于个性化免疫疗法的新型癌症抗原：最新证据和临床潜力
- 作者：Gregory T. Wurz;Chiao-Jung Kao;Michael W. DeGregorio
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第1期
- antitumor antibody cancer-testis antigen cancer vaccine immunotherapy oncofetal antigen tumor-associated antigen;
25.ALK inhibitors in non-small cell lung cancer: the latest evidence and developments

机译：非小细胞肺癌中的ALK抑制剂：最新证据和进展
- 作者：Ivana Sullivan;David Planchard
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第1期
- alectinib ALK rearrangement ceritinib crizotinib NSCLC resistance;
26.Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy

机译：BRAF和MEK抑制剂联合治疗黑色素瘤的最新证据和治疗方法
- 作者：Zeynep Eroglu;Antoni Ribas
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第1期
- BRAF inhibitors MEK inhibitors melanoma;
27.Pharmacologic resistance in colorectal cancer: a review

机译：结直肠癌的药理抗药性：综述
- 作者：William A. Hammond;Abhisek Swaika;Kabir Mody
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第1期
- colon adenocarcinoma colon cancer resistance;
28.Postmastectomy radiation therapy after neoadjuvant chemotherapy: review and interpretation of available data

机译：新辅助化疗后的乳房切除术后放疗：现有数据的回顾和解释
- 作者：Amar U. Kishan;Susan A. McCloskey
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2016年第1期
- post-mastectomy radiotherapy neoadjuvant chemotherapy pathologic complete response;
29.Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice

机译：瑞戈非尼在转移性胃肠道间质瘤中的个性化治疗在现实生活中的临床实践
- 作者：Margherita Nannini;Maria Concetta Nigro;Bruno Vincenzi;Elena Fumagalli;Giovanni Grignani;Lorenzo D’Ambrosio;Giuseppe Badalamenti;Lorena Incorvaia;Raffaella Bracci;Silvia Gasperoni;Maristella Saponara;Lidia Gatto;Valentina Indio;Annalisa Astolfi;Valerio Di Scioscio;Paolo G. Casali;Giuseppe Tonini;Massimo Aglietta;Antonio Russo;Guido Biasco;Maria A. Pantaleo
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第12期
- GIST personalized treatment quality of life referral centres regorafenib tyrosine kinase inhibitors;
30.DNM3 p65 and p53 from exosomes represent potential clinical diagnosis markers for glioblastoma multiforme

机译：外泌体的DNM3p65和p53代表多形性胶质母细胞瘤的潜在临床诊断标记
- 作者：Jian-kai Yang;Jian Song;Hao-ran Huo;Yin-long Zhao;Guang-yu Zhang;Zong-mao Zhao;Guo-zhu Sun;Bao-hua Jiao
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第12期
- exosomes DNM3 glioblastoma multiforme (GBM) p53 p65;
31.Myxofibrosarcoma primary cultures: molecular and pharmacological profile

机译：黏膜纤维肉瘤原代培养：分子和药理学概况
- 作者：Alessandro De Vita;Federica Recine;Laura Mercatali;Giacomo Miserocchi;Chiara Liverani;Chiara Spadazzi;Roberto Casadei;Alberto Bongiovanni;Federica Pieri;Nada Riva;Dino Amadori;Toni Ibrahim
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第12期
- CD109 chemotherapy high-grade myxofibrosarcoma primary culture TGF-β;
32.Atezolizumab: feasible second-line therapy for patients with non-small cell lung cancer? A review of efficacy safety and place in therapy

机译：Atezolizumab：非小细胞肺癌患者的二线治疗可行吗？疗效安全性和治疗位置的综述
- 作者：Fanny Jean;Pascale Tomasini;Fabrice Barlesi
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第12期
- atezolizumab immunotherapy lung cancer PD-L1 second-line;
33.Targeted therapy of brain metastases: latest evidence and clinical implications

机译：脑转移瘤的靶向治疗：最新证据和临床意义
- 作者：Rodica Di Lorenzo;Manmeet S. Ahluwalia
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第12期
- brain metastases targeted therapy;
34.FOXC1 in cancer development and therapy: deciphering its emerging and divergent roles

机译：FOXC1在癌症的发展和治疗中：破译其新兴和不同的作用
- 作者：Zhi Yang;Shuai Jiang;Yicheng Cheng;Tian Li;Wei Hu;Zhiqiang Ma;Fulin Chen;Yang Yang
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第12期
- biomarker cancer metastasis cell proliferation forkhead box C1 tumor;
35.Somatostatin analogs: is one better than other?

机译：生长抑素类似物：一种比其他更好吗？
- 作者：Berardi Rossana;Partelli Stefano;Cascinu Stefano;Falconi Massimo
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第12期
36.Transarterial infusion of epirubicin and cisplatin combined with systemic infusion of 5-fluorouracil versus transarterial chemoembolization using doxorubicin for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective analysis

机译：经动脉输注表柔比星和顺铂联合全身输注5-氟尿嘧啶与阿霉素经动脉化疗栓塞治疗合并门静脉瘤栓塞的不可切除肝细胞癌：回顾性分析
- 作者：Sung Won Lee;Hae Lim Lee;Nam Ik Han;Jung Hyun Kwon;Soon Woo Nam;Jeong Won Jang;Si Hyun Bae;Jong Young Choi;Seung Kew Yoon
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第10期
- cisplatin epirubicin 5-fluorouracil hepatocellular carcinoma portal vein tumor thrombosis;
37.Cabozantinib in metastatic renal cell carcinoma: latest findings and clinical potential

机译：卡博替尼治疗转移性肾细胞癌的最新发现和临床潜力
- 作者：Melissa Bersanelli;Sebastiano Buti
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第10期
- cabozantinib kidney cancer treatment metastatic renal cell carcinoma renal cell carcinoma tyrosine kinase inhibitors;
38.Managing sarcoma: where have we come from and where are we going?

机译：处理肉瘤：我们来自哪里我们要去哪里？
- 作者：Jenna S. Bleloch;Reyna D. Ballim;Serah Kimani;Jeannette Parkes;Eugenio Panieri;Tarryn Willmer;Sharon Prince
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第10期
- chemotherapy current management new therapies radiation therapy sarcoma surgery targeted therapies;
39.Niraparib in ovarian cancer: results to date and clinical potential

机译：尼拉帕利在卵巢癌中的作用：迄今为止的结果和临床潜力
- 作者：Davide Caruso;Anselmo Papa;Silverio Tomao;Patrizia Vici;Pierluigi Benedetti Panici;Federica Tomao
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第9期
- BRCA mutations BRCAness epithelial ovarian cancer high-grade serous ovarian cancer homologous recombination deficiency (HRD) niraparib poly(ADP-ribose) polymerase inhibitors (PARPis) synthetic lethality concept target therapy;
40.Treating KRAS-mutant NSCLC: latest evidence and clinical consequences

机译：治疗KRAS突变型NSCLC：最新证据和临床后果
- 作者：Pilar Garrido;María Eugenia Olmedo;Ana Gómez;Luis Paz Ares;Fernando López-Ríos;Juan Manuel Rosa-Rosa;José Palacios
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第9期
- genomic profiling KRAS non-small cell lung cancer predictive factor prognostic factor;
41.Clinical staging of NSCLC: current evidence and implications for adjuvant chemotherapy

机译：NSCLC的临床分期：辅助化疗的最新证据和意义
- 作者：David J. Heineman;Johannes M. Daniels;Wilhelmina H. Schreurs
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第9期
- adjuvant carcinoma chemoradiotherapy chemotherapy non-small cell lung cancer radiosurgery radiotherapy thoracic surgery;
42.BRCA mutation in ovarian cancer: testing implications and treatment considerations

机译：卵巢癌中的BRCA突变：测试意义和治疗注意事项
- 作者：Robert T. Neff;Leigha Senter;Ritu Salani
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第8期
- BRCA mutations ovarian cancer PARP inhibitor;
43.Treatment of advanced metastatic soft tissue sarcoma: latest evidence and clinical considerations

机译：晚期转移性软组织肉瘤的治疗：最新证据和临床考虑
- 作者：Gino K. In;James S. Hu;William W. Tseng
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第8期
- eribulin high-grade immunotherapy metastatic olaratumab pazopanib sarcoma soft tissue trabectedin;
44.Recent developments in the treatment of metastatic colorectal cancer

机译：转移性结直肠癌治疗的最新进展
- 作者：Jonathan M. Loree;Scott Kopetz
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第8期
- advanced chemotherapy colon location rectal sidedness subtypes cancer;
45.Prognostic and predictive biomarkers in prostate cancer: latest evidence and clinical implications

机译：前列腺癌的预后和预测生物标志物：最新证据和临床意义
- 作者：Naoki Terada;Shusuke Akamatsu;Takashi Kobayashi;Takahiro Inoue;Osamu Ogawa;Emmanuel S Antonarakis
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第8期
- prostate cancer biomarker treatment castration-resistant prostate cancer;
46.Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale evidence and place in therapy

机译：Osimertinib在晚期表皮生长因子受体T790M突变阳性非小细胞肺癌患者中的作用：证据证据和治疗方法
- 作者：Biagio Ricciuti;Sara Baglivo;Luca Paglialunga;Andrea De Giglio;Guido Bellezza;Rita Chiari;Lucio Crinò;Giulio Metro
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第6期
- NSCLC EGFR tyrosine kinase inhibitors resistance osimertinib T790M liquid biopsy brain metastasis;
47.Review of the use of pretest probability for molecular testing in non-small cell lung cancer and overview of new mutations that may affect clinical practice

机译：审查非小细胞肺癌分子检测中使用前测概率的可能性以及可能影响临床实践的新突变概述
- 作者：Petra Martin;Natasha B. Leighl
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第6期
- EGFR mutation molecular testing non-small cell lung cancer pretest probability;
48.Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications

机译：软组织肉瘤的新辅助化疗：最新证据和临床意义
- 作者：Sandro Pasquali;Alessandro Gronchi
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第6期
- chemotherapy neoadjuvant radiotherapy soft tissue sarcoma trial;
49.Pembrolizumab in cervical cancer: latest evidence and clinical usefulness

机译：派姆单抗在宫颈癌中的作用：最新证据和临床实用性
- 作者：Edith Borcoman;Christophe Le Tourneau
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第6期
- cervical cancer immune checkpoints immunotherapy pembrolizumab;
50.Letter to the Editor Re: Ahn DH Krishna K Blazer M et al. A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis. Ther Adv Med Oncol https://doi.org/10.1177/1758834016676011

机译：致编辑的信Re：Ahn DHKrishna KBlazer M等。对转移性胰腺癌患者每两周一次吉西他滨和nab-紫杉醇的改良方案既可耐受又有效：是一项回顾性分析。 Ther Adv Med Oncol https://doi.org/10.1177/1758834016676011
- 作者：Daniel D Von Hoff;Markus F Renschler
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第6期
51.Response to Drs Von Hoff and Renschler

机译：Hoff和Renschler对Drs的回应
- 作者：Daniel H. Ahn;Tanios Bekaii-Saab
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第6期
52.Docetaxel in prostate cancer: a familiar face as the new standard in a hormone-sensitive setting

机译：多西紫杉醇治疗前列腺癌：激素敏感环境中新面孔成为熟悉的面孔
- 作者：Javier Puente;Enrique Grande;Ana Medina;Pablo Maroto;Nuria Lainez;Jose Angel Arranz
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第5期
- androgen antagonists antineoplastic agents/therapeutic use docetaxel hormone-sensitive neoplasm metastasis prostatic neoplasm/drug therapy taxoids/therapeutic use;
53.Abiraterone acetate and prednisone in chemotherapy-naïve prostate cancer patients: rationale evidence and clinical utility

机译：醋酸阿比特龙和泼尼松在未经化疗的前列腺癌患者中的应用：理论依据证据和临床应用
- 作者：E. David Crawford;Neal D. Shore;Daniel P. Petrylak;Celestia S. Higano;Charles J. Ryan
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第5期
- abiraterone acetate chemotherapy-naïve prednisone prostate cancer;
54.Hormonoresistance in advanced breast cancer: a new revolution in endocrine therapy

机译：晚期乳腺癌的激素抵抗：内分泌治疗的新革命
- 作者：Paule Augereau;Anne Patsouris;Emmanuelle Bourbouloux;Carole Gourmelon;Sophie Abadie Lacourtoisie;Dominique Berton Rigaud;Patrick Soulié;Jean Sebastien Frenel;Mario Campone
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第5期
- adaptive mechanism CDK4/6 inhibitor hormonoresistance PI3K/mTOR inhibitor;
55.History and current state of immunotherapy in glioma and brain metastasis

机译：胶质瘤和脑转移的免疫疗法的历史和现状
- 作者：Tresa McGranahan;Gordon Li;Seema Nagpal
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第5期
- brain neoplasms immunotherapy;
56.Cancer-induced muscle wasting: latest findings in prevention and treatment

机译：癌症引起的肌肉消瘦：预防和治疗的最新发现
- 作者：Zaira Aversa;Paola Costelli;Maurizio Muscaritoli
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第5期
- muscle wasting cancer cachexia nutritional intervention exercise multimodal treatment;
57.Clinical effectiveness and toxicity of second-line irinotecan in advanced gastric and gastroesophageal junction adenocarcinoma: a single-center observational study

机译：单线伊立替康在晚期胃和胃食管连接腺癌中的临床疗效和毒性：单中心观察性研究
- 作者：Sebastian Ochenduszko;Mirosława Puskulluoglu;Kamil Konopka;Kamil Fijorek;Agnieszka Julia Slowik;Michał Pędziwiatr;Andrzej Budzyński
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第4期
- gastric cancer gastroesophageal cancer irinotecan second-line chemotherapy;
58.Combination of metformin and curcumin targets breast cancer in mice by angiogenesis inhibition immune system modulation and induction of p53 independent apoptosis

机译：二甲双胍和姜黄素的组合通过抑制血管生成调节免疫系统和诱导p53独立凋亡来靶向治疗小鼠乳腺癌
- 作者：Rabah Rashad Falah;Wamidh H. Talib;Seba Jamal Shbailat
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第4期
- breast cancer combination therapy curcumin metformin;
59.PARP inhibitors in ovarian cancer: evidence experience and clinical potential

机译：卵巢癌中的PARP抑制剂：证据经验和临床潜力
- 作者：Tarra Evans;Ursula Matulonis
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第4期
- PARP inhibitors ovarian cancer BRCA mutations targeted therapy;
60.A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy

机译：内分泌治疗乳腺癌幸存者生殖泌尿症状的临床指南
- 作者：Mariana S. Sousa;Michelle Peate;Sherin Jarvis;Martha Hickey;Michael Friedlander
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第4期
- atrophy breast cancer endocrine therapy estrogen genitourinary symptoms management menopause oncology;
61.Moving beyond vascular endothelial growth factor-targeted therapy in renal cell cancer: latest evidence and therapeutic implications

机译：在肾细胞癌中超越以血管内皮生长因子为靶标的治疗方法：最新证据和治疗意义
- 作者：Che-Kai Tsao;Bobby Liaw;Catherine He;Matthew D. Galsky;John Sfakianos;William K. Oh
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第4期
- clear cell immunotherapy renal cell carcinoma targeted therapies vascular epidermal growth factor;
62.Reviewer Thank You List

机译：审稿人感谢名单
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第4期
63.Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccination

机译：NF-κB触发的树突状细胞表达默克尔细胞癌病毒致癌驱动物的临床前评价
- 作者：Kerstin F. Gerer;Michael Erdmann;Sine R. Hadrup;Rikke Lyngaa;Lena-Marie Martin;Reinhard E. Voll;Beatrice Schuler-Thurner;Gerold Schuler;Niels Schaft;Stefanie Hoyer;Jan Dörrie
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第7期
- adoptive cellular immunotherapy dendritic cells large T-antigen Merkel cell carcinoma polyomavirus;
64.Fulvestrant in advanced breast cancer: evidence to date and place in therapy

机译：晚期乳腺癌中的氟维西平：治疗中迄今的证据和位置
- 作者：Katalin Boér
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第7期
- advanced breast cancer endocrine therapy fulvestrant selective oestrogen receptor downregulator;
65.Treatment of NRAS-mutated advanced or metastatic melanoma: rationale current trials and evidence to date

机译：NRAS突变的晚期或转移性黑色素瘤的治疗：原理最新试验和迄今为止的证据
- 作者：Amélie Boespflug;Julie Caramel;Stephane Dalle;Luc Thomas
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第7期
- NRAS-mutant melanoma targeted therapies metastatic melanoma clinical trials;
66.Novel therapeutic strategies in the treatment of triple-negative breast cancer

机译：治疗三阴性乳腺癌的新型治疗策略
- 作者：Karima Oualla;Heba M. El-Zawahry;Banu Arun;James M. Reuben;Wendy A. Woodward;Heba Gamal El-Din;Bora Lim;Nawfel Mellas;Naoto T. Ueno;Tamer M. Fouad
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第7期
- chemotherapy clinical trials immunotherapy molecular subtypes targeted therapies triple-negative breast cancer;
67.Multi-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens

机译：含铂疗法失败后复发和转移性鼻咽癌患者使用奈达铂联合S-1化疗的多机构前瞻性研究
- 作者：Pei-Jian Peng;Bao-Jun Lv;Zhi-Hui Wang;Hai Liao;Yu-Meng Liu;Zhong Lin;Yun-Yan Con;Pei-Yu Huang
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第2期
- chemotherapy nasopharyngeal carcinoma nedaplatin S-1;
68.A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis

机译：回顾性分析：转移性胰腺癌患者每两周一次吉西他滨和nab-紫杉醇改良方案既可耐受又有效。
- 作者：Daniel H. Ahn;Kavya Krishna;Marlo Blazer;Joshua Reardon;Lai Wei;Christina Wu;Kristen K. Ciombor;Anne M. Noonan;Sameh Mikhail;Tanios Bekaii-Saab
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第2期
- efficacious gemcitabine-improved toxicity modified regimen nab-paclitaxel pancreatic cancer;
69.Progress with palbociclib in breast cancer: latest evidence and clinical considerations

机译：palbociclib在乳腺癌中的研究进展：最新证据和临床考虑
- 作者：Andrea Rocca;Alessio Schirone;Roberta Maltoni;Sara Bravaccini;Lorenzo Cecconetto;Alberto Farolfi;Giuseppe Bronte;Daniele Andreis
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第2期
- breast neoplasms CDK4/6 inhibitors cell cycle cyclin-dependent kinase 4/6 palbociclib retinoblastoma protein;
70.Antiangiogenic therapy for refractory colorectal cancer: current options and future strategies

机译：难治性结直肠癌的抗血管生成治疗：当前选择和未来策略
- 作者：Rachel Riechelmann;Axel Grothey
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第2期
- antiangiogenic biomarker colorectal cancer monoclonal antibody tyrosine kinase inhibitor;
71.Refractory carcinoid syndrome: a review of treatment options

机译：难治性类癌综合征：治疗选择的回顾
- 作者：Rachel P. Riechelmann;Allan A. Pereira;Juliana F. M. Rego;Frederico P. Costa
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第2期
- carcinoid syndrome neuroendocrine neoplasm somatostatin systematic review;
72.Muscle spasms: an unexpected adverse drug reaction of pemetrexed?

机译：肌肉痉挛：培美曲塞的意外药物不良反应？
- 作者：Hendrika J. A. de Rouw;Naomi T. Jessurun;Lucie J. P. Masen-Poos;Hieronymus J. Derijks
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第2期
- adverse drug reaction muscle spasms non-small cell lung cancer pemetrexed;
73.Predictive biomarkers and effectiveness of MUC1-targeted dendritic-cell-based vaccine in patients with refractory non-small cell lung cancer

机译：靶向MUC1的树突状细胞疫苗在难治性非小细胞肺癌患者中的预测生物标志物和有效性
- 作者：Koji Teramoto;Yoshitomo Ozaki;Jun Hanaoka;Satoru Sawai;Noriaki Tezuka;Shozo Fujino;Yataro Daigo;Keiichi Kontani
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第3期
- cancer immunotherapy dendritic-cell-based vaccine MUC1 tumor antigen non-small cell lung cancer predictive biomarker;
74.Liposomal irinotecan in gemcitabine-refractory metastatic pancreatic cancer: efficacy safety and place in therapy

机译：脂质体伊立替康在吉西他滨难治性转移性胰腺癌中的疗效安全性和治疗位置
- 作者：Emma Kipps;Kate Young;Naureen Starling
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第3期
- chemotherapy liposomal irinotecan metastatic pancreatic cancer MM-398 nal-Iri NAPOLI-1 pancreatic cancer PDAC PEP02 treatment;
75.Nivolumab in renal cell carcinoma: latest evidence and clinical potential

机译：尼武单抗治疗肾细胞癌的最新证据和临床潜力
- 作者：Camille Mazza;Bernard Escudier;Laurence Albiges
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第3期
- immune checkpoint inhibitor immunotherapy nivolumab programmed death-1 renal cell carcinoma;
76.Everolimus treatment for neuroendocrine tumors: latest results and clinical potential

机译：依维莫司治疗神经内分泌肿瘤：最新结果和临床潜力
- 作者：Sara Pusceddu;Elena Verzoni;Natialie Prinzi;Alessia Mennitto;Daniela Femia;Paolo Grassi;Laura Concas;Claudio Vernieri;Giuseppe Lo Russo;Giuseppe Procopio
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第3期
- everolimus neuroendocrine tumors RADIANT trials;
77.Current understanding and approach to well differentiated lung neuroendocrine tumors: an update on classification and management

机译：当前对高分化肺神经内分泌肿瘤的认识和方法：分类和治疗的最新进展
- 作者：Talal Hilal
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第3期
- bronchial carcinoid neuroendocrine tumor NET carcinoid tumor;
78.Treatment choice in epidermal growth factor receptor mutation-positive non-small cell lung carcinoma: latest evidence and clinical implications

机译：表皮生长因子受体突变阳性非小细胞肺癌的治疗选择：最新证据及临床意义
- 作者：Oscar Juan;Sanjay Popat
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第3期
- EGFR mutation non-small cell lung carcinoma tyrosine kinase inhibitors;
79.Erratum

机译：勘误表
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2017年第3期
80.Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer?

机译：免疫疗法与化学疗法和放射疗法的结合在肺癌中：这是否是癌症终结的开始？
- 作者：Chiara Lazzari;Niki Karachaliou;Alessandra Bulotta;Mariagrazia Viganó;Aurora Mirabile;Elena Brioschi;Mariacarmela Santarpia;Luca Gianni;Rafael Rosell;Vanesa Gregorc
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2018年第-1期
- chemotherapy immune checkpoint inhibitors immune evasion immune resistance non-small cell lung cancer PD-1 inhibitors PD-L1 PD-L1 inhibitors radiotherapy;
81.PD-L1 expression testing in non-small cell lung cancer

机译：PD-L1在非小细胞肺癌中的表达检测
- 作者：Cristina Teixidó;Noelia Vilariño;Roxana Reyes;Noemí Reguart
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2018年第-1期
- immunotherapy immunohistochemistry (IHC) non-small cell lung cancer (NSCLC) PD-L1 expression testing predictive biomarker;
82.Science and biology drives the immune system to cure lung cancer patients: a revolution but not without challenges

机译：科学和生物学驱动免疫系统治愈肺癌患者：一场革命但并非没有挑战
- 作者：Niki Karachaliou;Rafael Rosell
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2018年第-1期
- anti-PD-1/PD-L1 biomarkers combinations immunotherapy lung cancer;
83.STAT3 as a potential immunotherapy biomarker in oncogene-addicted non-small cell lung cancer

机译：STAT3作为致癌基因上瘾的非小细胞肺癌的潜在免疫治疗生物标志物
- 作者：Ilaria Attili;Niki Karachaliou;Laura Bonanno;Jordi Berenguer;Jillian Bracht;Jordi Codony-Servat;Carles Codony-Servat;Masaoki Ito;Rafael Rosell
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2018年第-1期
- biomarkers immunotherapy lung cancer PD-L1 STAT3;
84.Clinical assessment of immune-related adverse events

机译：免疫相关不良事件的临床评估
- 作者：Aaron Sosa;Esther Lopez Cadena;Cristina Simon Olive;Niki Karachaliou;Rafael Rosell
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2018年第-1期
- anti-CTLA-4 anti-PD-1 anti-PD-L1 corticosteroids immunotherapy immune checkpoint inhibitors immune-related adverse events immunosuppression toxicity;
85.Estrogenicity of essential oils is not required to relieve symptoms of urogenital atrophy in breast cancer survivors

机译：不需要精油的雌激素性来缓解乳腺癌幸存者泌尿生殖道萎缩的症状
- 作者：Bruno M. Simões;Bertram Kohler;Robert B. Clarke;Jacqui Stringer;Lily Novak-Frazer;Keely Young;Riina Rautemaa-Richardson;Giorgia Zucchini;Anne Armstrong;Sacha J. Howell
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2018年第-1期
- breast cancer essential oil estrogen symptomatic urogenital atrophy;
86.First-line treatment of ovarian cancer: questions and controversies to address

机译：卵巢癌一线治疗：需要解决的问题和争议
- 作者：Jonathan A. Ledermann
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2018年第-1期
87.Tumour necrosis factor interferon-gamma and interleukins as predictive markers of antiprogrammed cell-death protein-1 treatment in advanced non-small cell lung cancer: a pragmatic approach in clinical practice

机译：肿瘤坏死因子干扰素-γ和白介素作为抗编程性细胞死亡蛋白-1治疗晚期非小细胞肺癌的预测指标：临床实践中的一种实用方法
- 作者：Efimia Boutsikou;Kalliopi Domvri;Georgia Hardavella;Dora Tsiouda;Konstantinos Zarogoulidis;Theodoros Kontakiotis
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2018年第-1期
- anti-PD-1 treatment interferon-γ interleukins non-small lung cancer predictive markers tumour necrosis factor;
88.Radiotherapy and checkpoint inhibitors: a winning new combination?

机译：放疗和检查点抑制剂：新的成功组合？
- 作者：Eric C. Ko;Silvia C. Formenti
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2018年第-1期
- Radiotherapy immunotherapy immune checkpoint blockade checkpoint inhibitors CTLA-4 PD-1 PD-L1 metastatic disease abscopal effect stereotactic body radiation therapy;
89.Development and 10-year history of a biosimilar: the example of Binocrit®

机译：生物仿制药的开发和十年历史：以Binocrit®为例
- 作者：Matti Aapro;Andriy Krendyukov;Nadja Höbel;Andreas Seidl;Pere Gascón
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2018年第-1期
- Binocrit biosimilars chemotherapy-induced anemia HX575;
90.Metformin prevents nerve growth factor-dependent proliferative andproangiogenic effects in epithelial ovarian cancer cells and endothelialcells

机译：二甲双胍可预防神经生长因子依赖性增殖和在上皮性卵巢癌细胞和内皮中的促血管生成作用细胞
- 作者：Maritza P. Garrido;Carolina Vera;Margarita Vega;Andrew F.G. Quest;Carmen Romero
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2018年第-1期
- angiogenesis endothelial cells metformin NGF ovarian cancer cells proliferation;
91.Immunotherapy in non-metastatic non-small cell lung cancer: Can the benefits of stage IV therapy be translated into earlier stages?

机译：非转移性非小细胞肺癌的免疫治疗：可以将IV期治疗的益处转化为早期阶段吗？
- 作者：Griet Deslypere;Dorothée Gullentops;Els Wauters;Johan Vansteenkiste
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2018年第-1期
- adjuvant therapy early stage immune checkpoint inhibitors locally advanced stage neoadjuvant therapy non-small cell lung cancer review targeted therapy;
92.Precision diagnostics of Ewing’s sarcoma by liquid biopsy: circulating EWS-FLI1 fusion transcripts

机译：液体活检精确诊断尤文氏肉瘤：循环的EWS-FLI1融合转录本
- 作者：Matteo Allegretti;Beatrice Casini;Chiara Mandoj;Stefania Benini;Laurent Alberti;Mariangela Novello;Elisa Melucci;Laura Conti;Renato Covello;Edoardo Pescarmona;Giuseppe Maria Milano;Alessio Annovazzi;Vincenzo Anelli;Virginia Ferraresi;Roberto Biagini;Patrizio Giacomini
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2018年第-1期
- circulating tumor RNA Ewing’s sarcoma EWS-FL1 gene rearrangements liquid biopsy PET imaging;
93.Optimizing (neo)adjuvant treatment of HER2-positive breastcancer

机译：优化（新）HER2阳性乳腺癌的辅助治疗癌症
- 作者：Reva K. Basho;Heather L. McArthur
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2018年第-1期
- adjuvant breast cancer HER2+ breast cancer neoadjuvant targeted therapy;
94.Precision medicine applications in prostate cancer

机译：精密医学在前列腺癌中的应用
- 作者：Edel M. McCrea;Daniel K. Lee;Tristan M. Sissung;William D. Figg
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2018年第-1期
- androgen deprivation therapy resistance AR-V7 microsatellite instability organic anion transporting polypeptide 1B3 precision medicine sex determining region Y box2;
95.Should age impact breast cancer management in young women? Fine tuning of treatment guidelines

机译：年龄会影响年轻女性的乳腺癌管理吗？微调治疗准则
- 作者：Matteo B. Suter;Olivia Pagani
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2018年第-1期
- breast cancer fertility premenopausal review young women;
96.The role of abemaciclib in treatment of advanced breast cancer

机译：abemaciclib在晚期乳腺癌治疗中的作用
- 作者：Amelia McCartney;Erica Moretti;Giuseppina Sanna;Marta Pestrin;Emanuela Risi;Luca Malorni;Laura Biganzoli;Angelo Di Leo
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2018年第-1期
- abemaciclib breast cancer CDK4/6 ER positive HER2 negative metastatic palbociclib ribociclib;
97.Prospective single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis

机译：加压腹膜内气雾化学疗法（PIPAC）对腹膜转移的前瞻性单中心实施和反应评估
- 作者：Martin Graversen;Sönke Detlefsen;Jon Kroll Bjerregaard;Claus Wilki Fristrup;Per Pfeiffer;Michael Bau Mortensen
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2018年第-1期
- aerosol carcinomatosis intraperitoneal metastasis palliative treatment peritoneum;
98.Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selection

机译：黑色素瘤和肾癌的免疫检查点抑制剂：从测序到合理选择
- 作者：Michael Flynn;Lisa Pickering;James Larkin;Samra Turajlic
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2018年第-1期
- biomarkers immune-checkpoint inhibitors melanoma renal cell carcinoma resistance sequencing targeted therapies;
99.Optimal management of luminal breast cancer: how much endocrine therapy is long enough?

机译：腔内乳腺癌的最佳管理：多少种内分泌治疗足够长？
- 作者：Elisabetta Munzone;Marco Colleoni
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2018年第-1期
- aromatase inhibitor breast cancer gene-expression profiling hormone receptor-positive breast cancer hormone therapy luminal breast cancer molecular testing tamoxifen;
100.Frequency impact and a preclinical study of novelERBB gene family mutations in HER2-positive breastcancer

机译：频率影响和小说的临床前研究HER2阳性乳腺癌中的ERBB基因家族突变癌症
- 作者：Naomi Elster;Sinead Toomey;Yue Fan;Mattia Cremona;Clare Morgan;Karolina Weiner Gorzel;Una Bhreathnach;Malgorzata Milewska;Madeline Murphy;Stephen Madden;Jarushka Naidoo;Joanna Fay;Elaine Kay;Aoife Carr;Sean Kennedy;Simon Furney;Janusz Mezynski;Oscar Breathhnach;Patrick Morris;Liam Grogan;Arnold Hill;Susan Kennedy;John Crown;William Gallagher;Bryan Hennessy;Alex Eustace
- 期刊名称：《Therapeutic Advances in Medical Oncology》 | 2018年第-1期
- breast cancer HER2+ BC PI3K PI3K inhibition somatic mutations trastuzumab resistance;